Sharps Technology, Inc. (STSS)
USD 4.75
(-9.35%)
USD 4.75
(-9.35%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -8.98 Million USD | 31.54% |
| 2022 | -2.66 Million USD | -202.17% |
| 2021 | -4.46 Million USD | -93.28% |
| 2020 | -2.32 Million USD | -12.87% |
| 2019 | -2.04 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -1.64 Million USD | 43.1% |
| 2024 Q2 | -1.72 Million USD | -4.81% |
| 2023 Q4 | -2.68 Million USD | -8.7% |
| 2023 FY | - USD | 31.61% |
| 2023 Q2 | -2.18 Million USD | 3.73% |
| 2023 Q3 | -2.46 Million USD | -12.95% |
| 2023 Q1 | -2.27 Million USD | 48.54% |
| 2022 Q4 | -4.41 Million USD | -323.25% |
| 2022 Q3 | -1.04 Million USD | 85.25% |
| 2022 Q2 | -7.07 Million USD | -623.53% |
| 2022 Q1 | -977.23 Thousand USD | 30.58% |
| 2022 FY | - USD | -202.17% |
| 2021 Q1 | -915.14 Thousand USD | -7.55% |
| 2021 FY | - USD | -93.28% |
| 2021 Q3 | -1.33 Million USD | -65.8% |
| 2021 Q2 | -807.38 Thousand USD | 11.77% |
| 2021 Q4 | -1.4 Million USD | -5.17% |
| 2020 Q4 | -850.86 Thousand USD | -38.72% |
| 2020 Q3 | -613.35 Thousand USD | 0.0% |
| 2020 FY | - USD | -12.87% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -45.63 Million USD | 80.32% |
| AngioDynamics, Inc. | -14.29 Million USD | 37.165% |
| AtriCure, Inc. | -8.1 Million USD | -10.746% |
| Avinger, Inc. | -16.34 Million USD | 45.061% |
| Azenta, Inc. | 55.15 Million USD | 116.283% |
| BioLife Solutions, Inc. | -45.23 Million USD | 80.149% |
| The Cooper Companies, Inc. | 882.8 Million USD | 101.017% |
| Daxor Corporation | 329.74 Thousand USD | 2823.476% |
| Ekso Bionics Holdings, Inc. | -13.19 Million USD | 31.956% |
| Femasys Inc. | -13.16 Million USD | 31.809% |
| GlucoTrack, Inc. | -7.09 Million USD | -26.645% |
| Harvard Bioscience, Inc. | 9.49 Million USD | 194.6% |
| Hologic, Inc. | 1.29 Billion USD | 100.693% |
| ICU Medical, Inc. | 307.69 Million USD | 102.919% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 100.375% |
| KORU Medical Systems, Inc. | -9.39 Million USD | 4.46% |
| LeMaitre Vascular, Inc. | 48.99 Million USD | 118.331% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -36.581% |
| Innovative Eyewear, Inc. | -6.57 Million USD | -36.581% |
| Masimo Corporation | 236.7 Million USD | 103.794% |
| Microbot Medical Inc. | -10.63 Million USD | 15.55% |
| Meihua International Medical Technologies Co., Ltd. | 15.77 Million USD | 156.944% |
| Merit Medical Systems, Inc. | 231.44 Million USD | 103.88% |
| Nephros, Inc. | -1.37 Million USD | -551.225% |
| NovoCure Limited | -175.86 Million USD | 94.894% |
| NEXGEL, Inc. | -2.73 Million USD | -228.952% |
| NEXGEL, Inc. | -2.73 Million USD | -228.952% |
| Singular Genomics Systems, Inc. | -86.49 Million USD | 89.618% |
| OraSure Technologies, Inc. | 76.15 Million USD | 111.792% |
| Pro-Dex, Inc. | 8.33 Million USD | 207.769% |
| Pulse Biosciences, Inc. | -42.36 Million USD | 78.803% |
| Predictive Oncology Inc. | -13.18 Million USD | 31.874% |
| Precision Optics Corporation, Inc. | -2.51 Million USD | -257.507% |
| QuidelOrtho Corporation | 545.6 Million USD | 101.646% |
| Repligen Corporation | 124.29 Million USD | 107.225% |
| Sanara MedTech Inc. | -289.09 Thousand USD | -3006.359% |
| STAAR Surgical Company | 33.22 Million USD | 127.032% |
| Utah Medical Products, Inc. | 24.8 Million USD | 136.204% |
| DENTSPLY SIRONA Inc. | 232 Million USD | 103.871% |
| Jin Medical International Ltd. | 3.44 Million USD | 360.839% |